Park Edge Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Hold
2,990
0.05% 143
2026
Q1
$259K Hold
2,990
0.06% 124
2025
Q4
$287K Hold
2,990
0.07% 123
2025
Q3
$285K Hold
2,990
0.07% 124
2025
Q2
$261K Sell
2,990
-350
-10% -$29.7K 0.07% 126
2025
Q1
$300K Sell
3,340
-235
-7% -$21K 0.08% 114
2024
Q4
$286K Sell
3,575
-700
-16% -$60.6K 0.08% 115
2024
Q3
$385K Hold
4,275
0.11% 100
2024
Q2
$336K Sell
4,275
-339
-7% -$27.8K 0.1% 106
2024
Q1
$402K Sell
4,614
-722
-14% -$61.6K 0.11% 88
2023
Q4
$440K Hold
5,336
0.15% 75
2023
Q3
$418K Hold
5,336
0.15% 67
2023
Q2
$470K Hold
5,336
0.16% 64
2023
Q1
$430K Sell
5,336
-312
-6% -$25.4K 0.17% 59
2022
Q4
$439K Buy
+5,648
New +$458K 0.19% 57

Other funds holding MDT

Park Edge Advisors's MDT Position: Q2 2026 in Review

Park Edge Advisors held its Medtronic (MDT) position steady in Q2 2026 at 2,990 shares worth $234K. The position accounts for 0.05% of the portfolio, ranked #143.

Park Edge Advisors first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $470K in Q2 2023. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Park Edge Advisors held 2,990 shares of Medtronic worth $234K as of Q2 2026.
  • Park Edge Advisors left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.05% of Park Edge Advisors's portfolio in Q2 2026, its #143 holding.
  • Park Edge Advisors first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • Park Edge Advisors's Medtronic position peaked at $470K in Q2 2023.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Park Edge Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.